Renal Perfusion, Filtration and Oxygenation During Cardiopulmonary Bypass (CPB)
NCT ID: NCT02405195
Last Updated: 2019-05-07
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
28 participants
OBSERVATIONAL
2011-10-31
2016-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Cardiopulmonary Bypass Flow on Renal Oxygenation, Blood Flow and Tubular Injury
NCT04084301
Impact of CArdiopulmonary Bypass Flow on Renal Blood Flow, Function and OXygenation
NCT02549066
Optimizing Pulsatility During Cardiopulmonary Bypass
NCT05344573
Pronostic Value of Gap CO2 During Cardiac Pulmonary Bypass in Cardiac Surgery: a Multicenter Retrospective Study
NCT06710275
Kidney Function in Diabetics During CPB (Cardio Pulmonary Bypass)
NCT03405532
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
cardiopulmonary bypass
During cardiac surgery, the subjects are routinely undergoing cardiopulmonary bypass
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Normal preoperative S-creatinine
Exclusion Criteria
* Cardiac transplantation och dissection
19 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sahlgrenska University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lukas Lannemyr
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sven-Erik Ricksten, Professor
Role: PRINCIPAL_INVESTIGATOR
Sahlgrenska Academy, dept of clinical science
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of thoracic anesthesia, Sahlgrenska University Hospital
Gothenburg, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Lannemyr L, Bragadottir G, Redfors B, Ricksten SE. Effects of milrinone on renal perfusion, filtration and oxygenation in patients with acute heart failure and low cardiac output early after cardiac surgery. J Crit Care. 2020 Jun;57:225-230. doi: 10.1016/j.jcrc.2019.12.022. Epub 2020 Jan 6.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SahlgrenskaUHThoraxLL0
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.